ACTH: How to Interpret Your Result

What ACTH Is and Why Your Doctor Ordered It

ACTH stands for adrenocorticotropic hormone. Your pituitary gland releases it in short pulses throughout the day, and the adrenal glands respond by producing cortisol. Understanding this one number can tell your clinician whether a cortisol problem is coming from the brain or from the adrenal glands themselves.

The test is most often ordered alongside a morning cortisol when your clinician suspects adrenal insufficiency, Cushing syndrome, or an adrenal mass found on imaging. The Endocrine Society's 2016 clinical practice guideline on adrenal insufficiency recommends paired morning cortisol and ACTH as the first step in distinguishing primary from secondary disease.

The HPA Axis in Plain Language

Your hypothalamus releases corticotropin-releasing hormone (CRH). CRH tells the pituitary to release ACTH. ACTH travels in the bloodstream to the adrenal cortex, where it drives cortisol production. Cortisol then feeds back to suppress both CRH and ACTH. This loop is called the HPA (hypothalamic-pituitary-adrenal) axis.

When the adrenal glands fail, cortisol falls and ACTH climbs because that negative feedback is lost. When the pituitary fails, ACTH falls and the adrenal glands receive no signal, so cortisol falls too. The direction of ACTH is the key that separates these two very different problems.

Why This Matters Specifically for Women

Women are two to three times more likely than men to develop autoimmune Addison disease (primary adrenal insufficiency), the most common cause of high ACTH with low cortisol in outpatient settings. A 2019 registry study in the European Journal of Endocrinology confirmed a female predominance of approximately 70 percent in autoimmune Addison cohorts. Female-specific triggers such as postpartum immune activation, thyroid autoimmunity (which co-occurs with Addison in Schmidt syndrome), and PCOS-associated adrenal androgen excess mean that your hormonal history shapes how your ACTH result should be read.

What Is a Normal ACTH Level?

Most reference labs set the normal morning ACTH range at 10 to 60 pg/mL, drawn between 6 and 9 a.m. After an overnight fast. Some labs report this as 2.2 to 13.3 pmol/L. Check your own lab's reference interval because assay methods differ significantly between immunoradiometric and chemiluminescent platforms.

Timing Matters More Than Most Women Realize

ACTH follows a steep diurnal curve. Levels at midnight can be less than 10 pg/mL even in healthy women. A result drawn at 2 p.m. After a stressful commute is essentially uninterpretable without context. If your blood was not drawn between 6 and 9 a.m. In a calm state, ask your clinician whether the test should be repeated.

How Your Menstrual Cycle Shifts the Baseline

The HPA axis is not cycle-neutral. Estrogen increases corticotropin-binding globulin and modulates pituitary sensitivity to CRH. A 2019 study in Psychoneuroendocrinology found measurably higher ACTH stress responses in the luteal phase compared with the follicular phase in cycling women, meaning a high-normal result drawn in the luteal phase carries different weight than the same number drawn on cycle day 3. This is rarely accounted for in standard lab reporting. It is one area where women's-health-specific interpretation genuinely changes clinical decision-making.

What a High ACTH Means

A result consistently above 60 pg/mL, paired with low or low-normal cortisol, points toward primary adrenal insufficiency (Addison disease). A result that is dramatically elevated (often above 200 pg/mL) with high cortisol and clinical signs of cortisol excess is the signature of Cushing disease or ectopic ACTH syndrome.

The clinical framework is straightforward: read ACTH and cortisol together, never in isolation.

| ACTH | Cortisol | Most Likely Diagnosis | |------|----------|-----------------------| | High (>60 pg/mL) | Low (<3 mcg/dL at 8 a.m.) | Primary adrenal insufficiency (Addison disease) | | High (>200 pg/mL) | High (>20 mcg/dL) | Cushing disease (pituitary adenoma) or ectopic ACTH | | Low (<10 pg/mL) | Low | Secondary or tertiary adrenal insufficiency | | Normal to mildly high | Normal or mildly high | Physiologic stress, chronic illness, or no adrenal pathology |

Primary Adrenal Insufficiency (Addison Disease)

When the adrenal cortex is destroyed by autoimmunity, infection (historically tuberculosis), or infiltration, cortisol production collapses and the pituitary responds by driving ACTH as high as it can go. Values above 100 to 200 pg/mL with a morning cortisol below 3 mcg/dL are diagnostic in the right clinical picture, though The Endocrine Society recommends confirming with an ACTH stimulation test (250 mcg cosyntropin IV) rather than relying on a single baseline draw.

Women with type 1 diabetes, autoimmune thyroid disease, or vitiligo carry a substantially higher risk of autoimmune Addison. If you have one autoimmune condition and symptoms of fatigue, salt craving, dizziness on standing, or hyperpigmentation of the skin or gum line, that clinical picture combined with elevated ACTH warrants same-week evaluation, not watchful waiting.

Cushing Disease and Ectopic ACTH: The Other End of the Spectrum

Cushing syndrome (excess cortisol from any source) affects women three times more often than men. A 2020 review in the New England Journal of Medicine noted that the female-to-male ratio for pituitary-dependent Cushing disease (Cushing disease proper) is approximately 3:1. The classic signs in women include central weight gain, moon facies, easy bruising, menstrual irregularity, acne, hirsutism, and new-onset hypertension, symptoms that overlap substantially with PCOS and metabolic syndrome and cause significant diagnostic delay.

When ACTH is suppressed (below 10 pg/mL) and cortisol is high, the source is adrenal (autonomous adrenal adenoma or carcinoma), not pituitary. When ACTH is measurable or elevated and cortisol is high, the source is either a pituitary adenoma or an ectopic tumor secreting ACTH (most often a small cell lung carcinoma or bronchial carcinoid).

ACTH and Adrenal Androgen Excess in PCOS

About 20 to 30 percent of women with PCOS have a sub-type called adrenal androgen excess, where the adrenal glands (not just the ovaries) overproduce DHEAS and androstenedione in response to ACTH. In these women, ACTH levels are often in the high-normal range and DHEAS is elevated. A 2021 paper in Fertility and Sterility classified adrenal androgen excess as a distinct PCOS phenotype with a higher prevalence of insulin resistance and metabolic risk than the purely ovarian phenotype. If your PCOS workup shows elevated DHEAS but a normal free testosterone, asking your clinician to check morning ACTH alongside 17-hydroxyprogesterone helps rule out late-onset congenital adrenal hyperplasia, which can mimic PCOS almost perfectly.

What a Low ACTH Means

A low ACTH (below 10 pg/mL) paired with a low morning cortisol points toward the pituitary or hypothalamus as the problem, not the adrenal glands. This is called secondary adrenal insufficiency (pituitary origin) or tertiary adrenal insufficiency (hypothalamic origin).

The Most Common Cause Women Miss: Exogenous Steroids

The single most frequent cause of low ACTH and low cortisol in clinical practice is exogenous glucocorticoid use. Prednisone, dexamethasone, inhaled fluticasone at high doses, topical betamethasone applied over large body surface areas, and even epidural steroid injections can suppress the HPA axis. A 2019 Cochrane review found that suppression can persist for weeks to months after stopping steroids, with recovery time proportional to dose and duration of use. If you have taken any corticosteroid in the past six to twelve months, tell your clinician before the ACTH draw; otherwise the result will be misread.

Pituitary Disease and Lymphocytic Hypophysitis

Lymphocytic hypophysitis is an autoimmune inflammation of the pituitary gland that disproportionately affects women, particularly in the third trimester of pregnancy and the postpartum period. The pituitary swells, ACTH secretion falls, and secondary adrenal insufficiency follows. ACOG Practice Bulletin No. 224 does not address this specifically, but a 2019 case series in the Journal of Clinical Endocrinology and Metabolism found lymphocytic hypophysitis accounts for approximately 5 to 10 percent of postpartum pituitary disease presentations. A postpartum woman with persistent fatigue, inability to lactate (from prolactin deficiency), and low sodium should have ACTH and cortisol checked on the same morning draw.

ACTH in Pregnancy and the Postpartum Period

Pregnancy changes nearly every reference range in endocrinology, and ACTH is no exception. Standard reference intervals must not be applied during gestation.

Why ACTH Rises in Pregnancy

The placenta secretes its own CRH, which is biologically active and drives maternal ACTH upward, especially in the second and third trimesters. A landmark 1988 study by Goland and colleagues published in the Journal of Clinical Endocrinology and Metabolism showed that placental CRH rises exponentially from mid-pregnancy onward, pushing maternal ACTH and cortisol well above non-pregnant reference ranges. A morning ACTH of 80 to 100 pg/mL in the third trimester may be entirely normal; the same value in a non-pregnant woman warrants investigation.

Diagnosing Adrenal Disease During Pregnancy

Cushing syndrome in pregnancy is rare (estimated 0.7 per 100,000 pregnancies per year) but associated with serious maternal and fetal complications including gestational hypertension, gestational diabetes, preterm birth, and fetal growth restriction. A 2018 review in the European Journal of Endocrinology recommends 24-hour urinary free cortisol as the preferred screening test during pregnancy because salivary cortisol and low-dose dexamethasone suppression tests are less reliable in this population. ACTH interpretation in pregnancy requires a maternal-fetal medicine or endocrinology co-consultation.

Postpartum Adrenal Crisis Risk

Women with known or previously subclinical Addison disease face their highest crisis risk during labor and the immediate postpartum period. Standard stress dosing for vaginal delivery is 100 mg hydrocortisone IV at the onset of active labor, then 50 mg every 8 hours for 24 hours. The Endocrine Society guideline on adrenal insufficiency spells out this protocol explicitly. If you carry an Addison diagnosis or have been told your ACTH is elevated with low cortisol, this protocol should be documented in your birth plan before 34 weeks.

Lactation

Cortisol and ACTH both transfer into breast milk at low concentrations. Replacement-dose hydrocortisone (15 to 25 mg per day) used to treat adrenal insufficiency is considered compatible with breastfeeding by LactMed. Pharmacologic doses of prednisone or dexamethasone carry a higher transfer burden and should prompt a conversation with a lactation-aware prescriber about timing feeds around the dose.

How to Lower a High ACTH

The answer depends entirely on why ACTH is high. There is no single "lower your ACTH" strategy that applies across diagnoses.

When High ACTH Reflects Primary Adrenal Insufficiency

Here the goal is not to lower ACTH. High ACTH in this setting is a compensatory response to cortisol deficiency. The treatment is cortisol replacement, typically hydrocortisone 15 to 25 mg per day in divided doses (two-thirds in the morning, one-third mid-afternoon), which restores negative feedback and brings ACTH back into range. The Endocrine Society 2016 guideline specifies this dosing range for adults. Fludrocortisone 0.05 to 0.1 mg daily is added for mineralocorticoid replacement in primary disease.

When High ACTH Reflects Cushing Disease

A pituitary adenoma producing autonomous ACTH is treated first with transsphenoidal surgery. Remission rates range from 65 to 90 percent in experienced pituitary centers. When surgery fails or is not possible, second-line options include radiation, pasireotide (a somatostatin analogue that directly reduces pituitary ACTH secretion), cabergoline, or bilateral adrenalectomy. Mifepristone (Korlym) blocks cortisol at the receptor level and is FDA-approved for Cushing syndrome-associated hyperglycemia in adults who are not candidates for surgery.

Lifestyle Factors That Modulate HPA Axis Output

No supplement or lifestyle change will meaningfully lower pathologically elevated ACTH, and anyone claiming otherwise is selling something. Chronic psychological stress, sleep deprivation, and high-intensity exercise without adequate recovery all drive CRH and ACTH upward. A 2018 study in Psychoneuroendocrinology found that mindfulness-based stress reduction over 8 weeks reduced cortisol awakening response by roughly 14 percent in perimenopausal women with elevated perceived stress. These are meaningful quality-of-life effects, not primary treatments for adrenal disease.

How to Raise a Low ACTH

Low ACTH caused by pituitary suppression from exogenous steroids requires a slow, supervised taper that allows the hypothalamic-pituitary axis to recover at its own pace. Trying to speed this with supplements or stimulants is not evidence-based and can precipitate adrenal crisis.

Pituitary disease causing low ACTH (from a tumor, surgery, radiation, or lymphocytic hypophysitis) is managed with cortisol replacement while the underlying cause is treated. The ACTH number itself is not the target of therapy; restoring adequate cortisol is.

ACTH Across Life Stages: What Changes and When

Reproductive Years

Menstrual cycle phase affects HPA reactivity. The luteal phase is associated with blunted cortisol responses in some women and amplified ACTH responses in others. Oral contraceptives raise corticosteroid-binding globulin and total cortisol, potentially masking low cortisol states; if you are on combined hormonal contraception, your clinician may need salivary free cortisol rather than serum total cortisol to accurately interpret adrenal function.

Perimenopause

The transition to menopause is accompanied by increased HPA axis reactivity. Falling estrogen reduces the buffering effect estrogen normally provides against CRH. A 2021 study in Menopause found higher perceived stress scores and elevated morning cortisol in perimenopausal compared with premenopausal women at the same age. ACTH in the high-normal range during the menopause transition is not uncommon and should be interpreted alongside symptoms rather than treated reflexively.

Post-Menopause

After menopause, the diurnal ACTH rhythm flattens somewhat. HPA axis dysregulation in this period is associated with visceral adiposity, insulin resistance, and impaired sleep, a cluster that can look metabolically similar to mild hypercortisolism even when true Cushing syndrome is absent. If your post-menopausal workup flags a mildly elevated ACTH, a 1 mg overnight dexamethasone suppression test is the recommended next step before pursuing further imaging.

Who Should Get an ACTH Test and Who Should Not

This test is likely appropriate for you if:

• Your morning cortisol is below 10 mcg/dL or above 25 mcg/dL and your clinician cannot explain it
• You have symptoms of adrenal insufficiency: profound fatigue, orthostatic dizziness, salt craving, nausea, hyperpigmentation, unintentional weight loss
• You have symptoms of Cushing syndrome: rapid central weight gain, stretch marks wider than 1 cm, new hypertension before age 40, easy bruising, proximal muscle weakness
• You have PCOS with elevated DHEAS and want to rule out adrenal androgen excess or late-onset CAH
• You are postpartum with persistent fatigue, low sodium, and inability to produce breast milk despite attempts
• You are on long-term corticosteroids and your clinician is planning a taper

This test is not the right starting point if:

• You are testing for "adrenal fatigue" based on non-specific tiredness without cortisol data. "Adrenal fatigue" is not a recognized endocrine diagnosis per the Endocrine Society, and ACTH drawn without cortisol provides no actionable information.
• Your cortisol has already been confirmed normal on a well-timed morning draw.
• You are in the third trimester of pregnancy and your clinician is screening for general wellness rather than a specific adrenal indication.

How the ACTH Stimulation Test Differs From a Baseline ACTH Draw

The baseline ACTH draw tells you what your pituitary is currently secreting. The ACTH stimulation test (also called the cosyntropin stimulation test or Synacthen test) is a functional test that tells you how well your adrenal glands respond to a stimulus. In this test, 250 mcg of synthetic ACTH (cosyntropin) is given intravenously or intramuscularly, and cortisol is measured at 30 and 60 minutes. A cortisol response above 18 to 20 mcg/dL at 30 minutes is considered normal in most guidelines. A blunted response confirms adrenal insufficiency regardless of the cause.

The stimulation test is more sensitive for diagnosing adrenal insufficiency than a single baseline cortisol or ACTH draw. The Endocrine Society recommends it as the definitive diagnostic test when baseline cortisol falls in the indeterminate range (3 to 18 mcg/dL).

Women who have had their pituitary gland irradiated, who have large pituitary adenomas, or who have recently stopped long-term steroids may have a normal adrenal response to the stimulation test even when secondary adrenal insufficiency is present, because the adrenal glands have not yet fully atrophied. In this setting, an insulin tolerance test or metyrapone test provides more accurate HPA axis assessment, though both carry more procedural risk.